[New coronavirus infection COVID-19 as a trigger for the development of symptoms of ankylosing spondylitis. Case report].
Ter Arkh
; 93(5): 71517, 2021 May 15.
Article
em Ru
| MEDLINE
| ID: mdl-36286718
ABSTRACT
The novel coronavirus infection COVID-19 (SARS-CoV-2) is now known to cause a variety of extrapulmonary complications, including cardiovascular, neurological and dermatological complications, many of which occur or last several weeks after infection. We present a clinical case of a patient who first developed symptoms of ankylosing spondylitis 2 weeks after recovering from COVID-19. The patient was prescribed therapy in accordance with international and Russian recommendations for the management of patients with ankylosing spondylitis with a positive effect in the form of absence arthritis, enthesitis and reducing the inflammatory back pain.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Espondilite Anquilosante
/
COVID-19
Idioma:
Ru
Ano de publicação:
2021
Tipo de documento:
Article